AN2 Therapeutics ANTX
NASDAQ ANTX
$5.09 +0.08 (+1.60%)
At close: Sep 29, 2026 · 4:00 PM EDT

AN2 Therapeutics (ANTX) Share-based Compensation (2021 - 2026)

Updated

AN2 Therapeutics' Share-based Compensation was $972,000 in Q2 2026, down 51.4% from $2 million a year earlier and down 33.4% from the prior quarter.

Analysis

AN2 Therapeutics (ANTX) Share-based Compensation (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, AN2 Therapeutics' Share-based Compensation was $4.63 million through Jun 30, 2026, down 40.0% year-over-year; for FY2025, it came in at $6.25 million, down 25.1% from FY2024.

  • Share-based Compensation shows a four-year compound annual growth rate of 59.1% (FY2021 to FY2025).
  • In earlier years, Share-based Compensation was $8.34 million in FY2024 (-0.9%), $8.41 million in FY2023 (+91.6%), $4.39 million in FY2022 (+350.8%) and $974,000 in FY2021.
  • Quarterly Share-based Compensation has moved between $354,000 (Q3 2021) and $2.39 million (Q1 2024) over five years.
  • Compared with a year earlier, Share-based Compensation has declined for eight straight quarters, with an average decline of 27.3% over the last eight quarters.
  • The best year-over-year quarter for Share-based Compensation over five years was Q2 2022 (growth of 593.9%); the worst was Q3 2025 (a decline of 57.9%).
  • Per Business Quant data, ANTX's Share-based Compensation in the three quarters before Q2 2026 was $1.46 million (Q1 2026), $1.4 million (Q4 2025) and $801,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 AN2 Therapeutics 181.91 Mn 181.91 Mn - 972,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 972,000.00
Mar 31, 2026 1.46 Mn
Dec 31, 2025 1.40 Mn
Sep 30, 2025 801,000.00
Jun 30, 2025 2.00 Mn
Mar 31, 2025 2.05 Mn
Dec 31, 2024 1.78 Mn
Sep 30, 2024 1.90 Mn
Jun 30, 2024 2.27 Mn
Mar 31, 2024 2.39 Mn
Dec 31, 2023 2.23 Mn
Sep 30, 2023 2.17 Mn
Jun 30, 2023 1.94 Mn
Mar 31, 2023 2.07 Mn
Dec 31, 2022 1.47 Mn
Sep 30, 2022 1.23 Mn
Jun 30, 2022 1.24 Mn
Mar 31, 2022 449,000.00
Dec 31, 2021 433,000.00
Sep 30, 2021 354,000.00
API Access

AN2 Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ANTX&period=max&api_key=YOUR_API_KEY